We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+12.35%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$136B
AUM Growth
+$12.5B
(+10%)
Cap. Flow
-$1.5B
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
28.12%
Holding
295
New
4
Increased
72
Reduced
149
Closed
2
Avg Time Held
4
years
Top 10 Avg Time Held
4.5
years
Top 20 Avg Time Held
3.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$789M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$158M |
| 3 |
Pioneer Natural Resource Co.
PXD
|
+$91.7M |
| 4 |
CVS Health
CVS
|
+$88.1M |
| 5 |
Novartis
NVS
|
+$86.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$896M |
| 2 |
NVIDIA
NVDA
|
+$256M |
| 3 |
Amgen
AMGN
|
+$155M |
| 4 |
Cisco
CSCO
|
+$138M |
| 5 |
Adobe
ADBE
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.33% |
| 2 | Healthcare | 24.5% |
| 3 | Industrials | 15.11% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Financials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TUES
251
DELISTED
Tuesday Morning Corp
TUES
| $4.63M | ﹤0.01% |
2,183,400
-25,600
| -1% | -$56.9K |
2013 Q2
23 quarters
|
|
252
Lowe's Companies
LOW
$110B
| $4.49M | ﹤0.01% |
41,000
| – | – |
2016 Q1
12 quarters
|
|
|
MBII
253
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $4.01M | ﹤0.01% |
2,619,600
-6,000
| -0.2% | -$9.15K |
2013 Q3
22 quarters
|
|
254
Armstrong World Industries
AWI
$7.07B
| $3.73M | ﹤0.01% |
47,000
| – | – |
2016 Q4
9 quarters
|
|
255
Arista Networks
ANET
$224B
| $3.71M | ﹤0.01% |
188,800
+92,000
| +95% | +$1.46M |
2014 Q2
19 quarters
|
|
|
HABT
256
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $3.53M | ﹤0.01% |
326,000
| – | – |
2017 Q1
8 quarters
|
|
257
DELISTED
Diebold Nixdorf Incorporated
DBD
| $3.32M | ﹤0.01% |
300,000
| – | – |
2013 Q2
23 quarters
|
|
258
DELISTED
Comerica
CMA
| $3.2M | ﹤0.01% |
43,600
| – | – |
2013 Q2
23 quarters
|
|
259
Avis
CAR
$3.73B
| $2.79M | ﹤0.01% |
80,000
| – | – |
2015 Q2
15 quarters
|
|
260
Ingevity
NGVT
$2.4B
| $2.44M | ﹤0.01% |
23,100
-300
| -1% | -$30.1K |
2017 Q4
5 quarters
|
|
261
Resideo Technologies
REZI
$2.49B
| $2.44M | ﹤0.01% |
126,405
-3,482
| -3% | -$77.2K |
2018 Q4
1 quarter
|
|
262
TechnipFMC
FTI
$27.3B
| $2.41M | ﹤0.01% |
137,760
+50,938
| +59% | +$861K |
2018 Q4
1 quarter
|
|
263
Owens Corning
OC
$8.87B
| $2.4M | ﹤0.01% |
50,900
| – | – |
2018 Q2
3 quarters
|
|
|
GTT
264
DELISTED
GTT Communications, Inc.
GTT
| $2.17M | ﹤0.01% |
62,400
-300
| -0.5% | -$8.81K |
2017 Q4
5 quarters
|
|
265
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $2.09M | ﹤0.01% |
340,000
| – | – |
2013 Q4
21 quarters
|
|
266
Five Below
FIVE
$12.2B
| $1.76M | ﹤0.01% |
14,200
| – | – |
2018 Q2
3 quarters
|
|
|
HOME
267
DELISTED
At Home Group Inc.
HOME
| $1.73M | ﹤0.01% |
+97,100
| New | +$2.15M |
2019 Q1
0 quarters
|
|
268
Greif Class B
GEF.B
$4.2B
| $1.61M | ﹤0.01% |
33,000
| – | – |
2013 Q2
23 quarters
|
|
|
SIOX
269
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.4M | ﹤0.01% |
131,538
-662
| -0.5% | -$6.59K |
2015 Q2
15 quarters
|
|
|
AVYA
270
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $1.36M | ﹤0.01% |
81,100
| – | – |
2018 Q3
2 quarters
|
|
271
Signet Jewelers
SIG
$4.51B
| $1.34M | ﹤0.01% |
49,536
-300
| -0.6% | -$8.27K |
2016 Q4
9 quarters
|
|
272
Prestige Consumer Healthcare
PBH
$2.36B
| $1.27M | ﹤0.01% |
42,600
+14,500
| +52% | +$416K |
2017 Q4
5 quarters
|
|
|
MAXR
273
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $1.13M | ﹤0.01% |
282,000
| – | – |
2018 Q2
3 quarters
|
|
274
Controladora Vuela Compania de Aviacion
VLRS
$679M
| $1.13M | ﹤0.01% |
132,000
-8,900
| -6% | -$70.2K |
2013 Q4
21 quarters
|
|
|
CERN
275
DELISTED
Cerner Corp
CERN
| $1.11M | ﹤0.01% |
19,400
| – | – |
2013 Q2
23 quarters
|
|
Similar funds
Primecap Management's Q1 2019 Portfolio in Review
As of Q1 2019, Primecap Management held 295 positions worth $136B, up 10% from $123B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2019: portfolio turnover was 2%. Primecap Management opened 4 new positions and exited 2, leaving the 295-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2019 buy was Lyft: 500,000 shares worth $39.1M.
- Primecap Management added most to Elanco Animal Health in Q1 2019, an estimated $789M increase.
- Primecap Management's biggest Q1 2019 reduction was Eli Lilly, cutting an estimated $896M.
- Primecap Management fully exited MINDBODY, Inc. Class A Common Stock in Q1 2019, selling an estimated $5.84M.
- Primecap Management's ten largest holdings make up 28% of its $136B portfolio in Q1 2019.
- Primecap Management opened 4 new positions and closed 2 in Q1 2019.
- Primecap Management's portfolio value rose 10% quarter-over-quarter to $136B.
Based on Primecap Management's 13F filing for Q1 2019, filed 14 May 2019.